- Investing Ideas
- Japanese Pharmaceuticals & Biotech Healthy potentially undervalued
Japanese Pharmaceuticals & Biotech Healthy potentially undervalued
Results
12
Companies which are potentially undervalued and in an acceptable financial position.
12 companies
Otsuka Holdings
Market Cap: JP¥5.8t
Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.
4578
JP¥11,100.00
7D
-0.5%
1Y
48.8%
Kissei Pharmaceutical
Market Cap: JP¥169.3b
Researches, develops, manufactures, and sells pharmaceutical products primarily in Japan.
4547
JP¥4,085.00
7D
-3.4%
1Y
-7.3%
Sumitomo Pharma
Market Cap: JP¥559.8b
Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia.
4506
JP¥1,248.00
7D
-2.8%
1Y
1.0%
Astellas Pharma
Market Cap: JP¥3.9t
Engages in the research, development, manufacture, sale, and supply of pharmaceuticals in Japan and internationally.
4503
JP¥2,202.00
7D
1.6%
1Y
39.7%
Santen Pharmaceutical
Market Cap: JP¥606.1b
Engages in the research and development, production, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.
4536
JP¥1,884.00
7D
-4.5%
1Y
12.7%
Ono Pharmaceutical
Market Cap: JP¥1.1t
Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.
4528
JP¥2,384.00
7D
-2.1%
1Y
45.3%
Tsumura
Market Cap: JP¥284.5b
Engages in the production and sale of Kampo extract intermediates and granular Kampo formulations in Japan and internationally.
4540
JP¥3,817.00
7D
0.5%
1Y
2.8%
Shionogi
Market Cap: JP¥2.5t
Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.
4507
JP¥2,908.50
7D
1.9%
1Y
14.2%
Takeda Pharmaceutical
Market Cap: JP¥8.8t
Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products.
4502
JP¥5,513.00
7D
-2.4%
1Y
30.7%
Chugai Pharmaceutical
Market Cap: JP¥11.4t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥6,932.00
7D
-6.5%
1Y
-5.6%
Kyowa Kirin
Market Cap: JP¥1.3t
Engages in the research, development, manufacturing, and marketing of pharmaceuticals in Japan, the Americas, Europe, Asia, and internationally.
4151
JP¥2,554.50
7D
-2.4%
1Y
-1.2%
PeptiDream
Market Cap: JP¥121.7b
A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.
4587
JP¥947.20
7D
0.8%
1Y
-43.3%